Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06526286 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 32 days later Nov 2026 → Jan 2027
See other at-risk trials from University of Colorado, Denver

Record History

  1. Recruitment opened Primary completion pushed from Nov 2026 to Jan 2027 · Study sites: 0 to 1 · Start date changed from estimate of Jun 2026 to Jul 7, 2026 · 2 more Show 5 more changesShow less
    • Primary completion pushed from Nov 2026 to Jan 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2026 to Jul 7, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 3 entries
  2. Start date: Feb 2026 to Jun 2026v8
  3. Start date: Nov 2025 to Feb 2026v7
  4. Start date: Aug 2025 to Nov 2025 Primary completion date: Sep 2026 to Nov 2026 · Completion date: Mar 2027 to May 2027v6 Show 2 more changesShow less
    • Primary completion date: Sep 2026 to Nov 2026
    • Completion date: Mar 2027 to May 2027
  5. Start date: Mar 2025 to Aug 2025 Primary completion date: Apr 2026 to Sep 2026 · Completion date: Oct 2026 to Mar 2027v5 Show 2 more changesShow less
    • Primary completion date: Apr 2026 to Sep 2026
    • Completion date: Oct 2026 to Mar 2027
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Oct 2024 to Mar 2025v4
  2. Re-verified, no change to tracked fieldsv3
  3. Secondary endpoints: details revised at 1 of 3 entries Eligibility criteria expanded, about 4 wordsv2 Show 1 more changeShow less
    • Eligibility criteria expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the impact of clinical decision support (CDS) in the form of an alert to identify patients who may be at risk of opioid use disorder (OUD) and a clinical care pathway helping providers treating patients with opioid use disorder. The pathway provides health care providers with information and suggestions for screening and treatment of opioid use disorder, including treatment with medications. The 2022 Centers for Disease Control and Prevention (CDC) clinical practice guideline for prescribing opioids for pain recommends providers asses for and treat opioid use disorder using approved medications for opioid use disorder (MOUD). This project will implement a passive CDS alert when a provider prescribes an opioid to a patient who may be at risk of opioid use disorder. Providers will also have link access to a clinical care pathway providing support for OUD screening and treatment. Before and after comparisons of buprenorphine (a medication used to treat opioid use disorder) prescribing by providers and outcomes of patients will be examined based on medical records data collected during routine care. The study period will be approximately 18 months.
Trial Details
NCT Number NCT06526286
Lead Sponsor University of Colorado, Denver
Collaborators: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)
Conditions Medication Abuse, Harm Reduction, Opioid Use Disorder, Supportive Care
Enrollment 200,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov